Premium Nahrungsergänzungsmittel | artgerecht

Tamsulosin: Uses, Dosage & Side Effects

Tamsulosin is an alpha-blocker medication primarily used to relieve urinary symptoms caused by benign prostatic hyperplasia (BPH), helping to improve urine flow.

Regular tips about health Regular tips about health

Things worth knowing about "Tamsulosin"

Tamsulosin is an alpha-blocker medication primarily used to relieve urinary symptoms caused by benign prostatic hyperplasia (BPH), helping to improve urine flow.

What is Tamsulosin?

Tamsulosin is a prescription medication belonging to the class of selective alpha-1 adrenergic receptor blockers (alpha-blockers). It is primarily used to relieve lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland. In some cases, tamsulosin is also used to facilitate the spontaneous passage of kidney or ureteral stones.

Indications

Tamsulosin is mainly prescribed for the following conditions:

Benign Prostatic Hyperplasia (BPH): Relief of urinary symptoms including frequent urination, weak urine stream, urgency, and incomplete bladder emptying
Ureteral stones: Facilitating spontaneous passage of small stones in the ureter (off-label use in some countries)

Mechanism of Action

Tamsulosin acts as a selective antagonist at alpha-1A and alpha-1D adrenergic receptors, which are predominantly located in the prostate, bladder neck, and urethra. By blocking these receptors, tamsulosin relaxes the smooth muscle in these areas, reducing urethral resistance and making urination easier. Due to its selectivity for the alpha-1A receptor subtype, tamsulosin has a lower blood-pressure-lowering effect compared to non-selective alpha-blockers.

Dosage and Administration

The standard dose of tamsulosin is 0.4 mg once daily, preferably taken after a meal to improve tolerability. The capsule should be swallowed whole without chewing. In some cases, the dose may be increased to 0.8 mg. Tamsulosin is available as modified-release capsules, ensuring a steady release of the active ingredient throughout the day.

Side Effects

Like all medications, tamsulosin may cause side effects. The most common include:

Dizziness and orthostatic hypotension (drop in blood pressure when standing up)
Retrograde ejaculation (semen flowing backward into the bladder during orgasm)
Headache
Runny or stuffy nose (rhinitis)
Heart palpitations

A rare but clinically important side effect is Intraoperative Floppy Iris Syndrome (IFIS), which can occur during cataract surgery. Patients taking or who have previously taken tamsulosin should inform their ophthalmologist or surgeon prior to any eye procedure.

Drug Interactions

Tamsulosin may interact with several other medications:

PDE-5 inhibitors (e.g., sildenafil, tadalafil): increased risk of significant blood pressure drop
Other antihypertensive agents and alpha-blockers: enhanced blood pressure-lowering effect possible
CYP3A4 inhibitors (e.g., ketoconazole): may increase tamsulosin plasma concentrations

Contraindications

Tamsulosin should not be used in patients with:

Known hypersensitivity to tamsulosin or any excipients
History of orthostatic hypotension
Severe hepatic impairment

Treatment Context

Tamsulosin is a well-established first-line therapy for symptomatic BPH. It significantly improves the quality of life for affected patients, although it does not treat the underlying cause of prostate enlargement. If symptoms are insufficiently controlled, other treatment options such as 5-alpha reductase inhibitors (e.g., finasteride), combination therapy, or surgical procedures may be considered.

References

European Association of Urology (EAU) - Guidelines on Benign Prostatic Hyperplasia (2023). Available at: https://uroweb.org/guidelines/benign-prostatic-hyperplasia
Chapple CR et al. - Tamsulosin, the first prostate-selective alpha1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Urology, 1996.
Roehrborn CG - Benign prostatic hyperplasia: an overview. Reviews in Urology, 2005;7(Suppl 9):S3-S14.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.